Law360, New York ( February 28, 2017, 11:21 AM EST) -- On Dec. 13, 2016, President Obama signed the 21st Century Cures Act into law. While the act contains many provisions of interest to pharmaceutical (and medical device) companies, one provision that might easily have been overlooked is Section 3032....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.